12896_2019_559_MOESM4_ESM.pptx (44.67 kB)
MOESM4 of Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
presentation
posted on 2019-10-18, 09:28 authored by Alessandro Ascione, Claudia Arenaccio, Alessandra Mallano, Michela Flego, Mara Gellini, Mauro Andreotti, Craig Fenwick, Giuseppe Pantaleo, Stefano Vella, Maurizio FedericoAdditional file 4: Figure S7BII. Dose-response effect of the divalent scFvF7-Fc Ab and inhibition by recombinant LAG3 (Exp. II). For details see Legend of Fig. 7b. (PPTX 36 kb)